[HTML][HTML] Phase I study of celecoxib with concurrent irinotecan, cisplatin, and radiation therapy for patients with unresectable locally advanced non-small cell lung …
R Komaki, X Wei, PK Allen, Z Liao, L Milas… - Frontiers in …, 2011 - frontiersin.org
Purpose: Preclinical findings suggest that adding targeted therapies to combination
radiation-chemotherapy can enhance treatment efficacy; however, this approach may …
radiation-chemotherapy can enhance treatment efficacy; however, this approach may …
[HTML][HTML] Phase I Study of Celecoxib with Concurrent Irinotecan, Cisplatin, and Radiation Therapy for Patients with Unresectable Locally Advanced Non-Small Cell …
R Komaki, X Wei, PK Allen, Z Liao, L Milas… - Frontiers in …, 2011 - ncbi.nlm.nih.gov
Purpose: Preclinical findings suggest that adding targeted therapies to combination
radiation-chemotherapy can enhance treatment efficacy; however, this approach may …
radiation-chemotherapy can enhance treatment efficacy; however, this approach may …
[HTML][HTML] Phase I Study of Celecoxib with Concurrent Irinotecan, Cisplatin, and Radiation Therapy for Patients with Unresectable Locally Advanced Non-Small Cell …
R Komaki, X Wei, PK Allen, Z Liao, L Milas, JD Cox… - Frontiers in …, 2011 - osti.gov
Purpose: Preclinical findings suggest that adding targeted therapies to combination
radiation-chemotherapy can enhance treatment efficacy; however, this approach may …
radiation-chemotherapy can enhance treatment efficacy; however, this approach may …
Phase I study of celecoxib with concurrent irinotecan, cisplatin, and radiation therapy for patients with unresectable locally advanced non-small cell lung cancer
R Komaki, X Wei, PK Allen, Z Liao… - Frontiers in …, 2011 - mdanderson.elsevierpure.com
Purpose: Preclinical findings suggest that adding targeted therapies to combination
radiation-chemotherapy can enhance treatment efficacy; however, this approach may …
radiation-chemotherapy can enhance treatment efficacy; however, this approach may …
Phase I study of celecoxib with concurrent irinotecan, Cisplatin, and radiation therapy for patients with unresectable locally advanced non-small cell lung cancer
R Komaki, X Wei, PK Allen, Z Liao… - Frontiers in …, 2011 - pubmed.ncbi.nlm.nih.gov
Purpose Preclinical findings suggest that adding targeted therapies to combination radiation-
chemotherapy can enhance treatment efficacy; however, this approach may enhance …
chemotherapy can enhance treatment efficacy; however, this approach may enhance …
[PDF][PDF] Phase I study of celecoxib with concurrent irinotecan, cisplatin, and radiation therapy for patients with unresectable locally advanced non-small cell lung cancer
R Komaki, X Wei, PK Allen, Z Liao, L Milas, JD Cox… - scienceopen.com
Purpose: Preclinical findings suggest that adding targeted therapies to combination
radiation-chemotherapy can enhance treatment efficacy; however, this approach may …
radiation-chemotherapy can enhance treatment efficacy; however, this approach may …
[PDF][PDF] Phase I study of celecoxib with concurrent irinotecan, cisplatin, and radiation therapy for patients with unresectable locally advanced non-small cell lung cancer
R Komaki, X Wei, PK Allen, Z Liao, L Milas, JD Cox… - researchgate.net
Purpose: Preclinical findings suggest that adding targeted therapies to combination
radiation-chemotherapy can enhance treatment efficacy; however, this approach may …
radiation-chemotherapy can enhance treatment efficacy; however, this approach may …
Phase I Study of Celecoxib with Concurrent Irinotecan, Cisplatin, and Radiation Therapy for Patients with Unresectable Locally Advanced Non-Small Cell Lung …
R Komaki, X Wei, PK Allen, Z Liao, L Milas… - Frontiers in …, 2011 - inis.iaea.org
[en] Purpose: Preclinical findings suggest that adding targeted therapies to combination
radiation-chemotherapy can enhance treatment efficacy; however, this approach may …
radiation-chemotherapy can enhance treatment efficacy; however, this approach may …
Phase I study of celecoxib with concurrent irinotecan, Cisplatin, and radiation therapy for patients with unresectable locally advanced non-small cell lung cancer.
R Komaki, X Wei, PK Allen, Z Liao, L Milas… - Frontiers in …, 2011 - europepmc.org
Purpose Preclinical findings suggest that adding targeted therapies to combination radiation-
chemotherapy can enhance treatment efficacy; however, this approach may enhance …
chemotherapy can enhance treatment efficacy; however, this approach may enhance …
Phase I study of celecoxib with concurrent irinotecan, Cisplatin, and radiation therapy for patients with unresectable locally advanced non-small cell lung cancer.
R Komaki, X Wei, PK Allen, Z Liao, L Milas… - Frontiers in …, 2011 - europepmc.org
Purpose Preclinical findings suggest that adding targeted therapies to combination radiation-
chemotherapy can enhance treatment efficacy; however, this approach may enhance …
chemotherapy can enhance treatment efficacy; however, this approach may enhance …